O	0	8	Printing	Print	VBG	B-VP
O	9	17	solution	solution	NN	B-NP

O	18	25	Several	Several	JJ	B-NP
O	26	38	transfection	transfection	NN	I-NP
O	39	47	reagents	reagent	NNS	I-NP
O	48	52	were	be	VBD	B-VP
O	53	59	tested	test	VBN	I-VP
O	60	61	(	(	(	O
O	61	65	data	datum	NNS	B-NP
O	66	69	not	not	RB	B-VP
O	70	75	shown	show	VBN	I-VP
O	75	76	)	)	)	O
O	76	77	,	,	,	O
O	78	81	and	and	CC	O
O	82	84	we	we	PRP	B-NP
O	85	90	found	find	VBD	B-VP
O	91	95	that	that	IN	B-SBAR
O	96	99	the	the	DT	B-NP
O	100	101	X	X	NN	I-NP
O	101	102	-	-	HYPH	B-NP
O	102	111	tremeGENE	tremeGENE	NN	I-NP
O	112	117	siRNA	siRNA	NN	I-NP
O	118	130	transfection	transfection	NN	I-NP
O	131	138	reagent	reagent	NN	I-NP
O	139	140	(	(	(	O
O	140	145	Roche	Roche	NN	B-NP
O	145	146	)	)	)	O
O	147	151	gave	give	VBD	B-VP
O	152	156	good	good	JJ	B-NP
O	157	169	transfection	transfection	NN	I-NP
O	170	182	efficiencies	efficiency	NNS	I-NP
O	183	187	both	both	CC	B-PP
O	188	191	for	for	IN	B-PP
B-Cellular_component	192	200	plasmids	plasmid	NNS	B-NP
O	201	204	and	and	CC	I-NP
O	205	211	siRNAs	siRNA	NNS	I-NP
O	211	212	,	,	,	O
O	213	216	and	and	CC	O
O	217	222	chose	choose	VBD	B-VP
O	223	225	to	to	TO	I-VP
O	226	229	use	use	VB	I-VP
O	230	234	this	this	DT	B-NP
O	235	242	reagent	reagent	NN	I-NP
O	243	246	for	for	IN	B-PP
O	247	250	all	all	DT	B-NP
O	251	262	transfected	transfecte	VBN	I-NP
B-Cell	263	267	cell	cell	NN	I-NP
O	268	278	microarray	microarray	NN	I-NP
O	279	290	experiments	experiment	NNS	I-NP
O	291	293	in	in	IN	B-PP
O	294	297	the	the	DT	B-NP
O	298	305	present	present	JJ	I-NP
O	306	311	study	study	NN	I-NP
O	311	312	.	.	.	O

O	313	316	For	For	IN	B-PP
O	317	325	printing	print	VBG	B-VP
O	326	329	the	the	DT	B-NP
O	330	336	arrays	array	NNS	I-NP
O	336	337	,	,	,	O
O	338	341	one	one	CD	B-NP
O	342	347	major	major	JJ	I-NP
O	348	357	challenge	challenge	NN	I-NP
O	358	360	is	be	VBZ	B-VP
O	361	363	to	to	TO	B-VP
O	364	368	find	find	VB	I-VP
O	369	370	a	a	DT	B-NP
O	371	375	good	good	JJ	I-NP
O	376	383	balance	balance	NN	I-NP
O	384	391	between	between	IN	B-PP
O	392	396	high	high	JJ	B-NP
O	397	409	transfection	transfection	NN	I-NP
O	410	420	efficiency	efficiency	NN	I-NP
O	421	424	and	and	CC	O
O	425	434	spatially	spatially	RB	B-NP
O	435	443	confined	confine	VBN	I-NP
O	444	449	spots	spot	NNS	I-NP
O	450	452	to	to	TO	B-VP
O	453	458	avoid	avoid	VB	I-VP
O	459	464	cross	cross	AFX	B-NP
O	464	465	-	-	HYPH	I-NP
O	465	478	contamination	contamination	NN	I-NP
O	479	486	between	between	IN	B-PP
O	487	490	the	the	DT	B-NP
O	491	496	spots	spot	NNS	I-NP
O	496	497	.	.	.	O

O	498	500	In	In	IN	B-SBAR
O	501	506	order	order	NN	O
O	507	509	to	to	TO	B-VP
O	510	518	optimize	optimize	VB	I-VP
O	519	522	the	the	DT	B-NP
O	523	530	reverse	reverse	JJ	I-NP
O	531	543	transfection	transfection	NN	I-NP
O	544	552	protocol	protocol	NN	I-NP
O	553	556	for	for	IN	B-PP
B-Cell	557	560	HEK	HEK	NN	B-NP
I-Cell	561	567	293ind	293ind	CD	I-NP
I-Cell	567	568	-	-	HYPH	I-NP
I-Cell	568	572	ICER	ICER	NN	I-NP
I-Cell	573	580	IIgamma	IIgamma	NN	I-NP
I-Cell	581	586	cells	cell	NNS	I-NP
O	587	588	(	(	(	O
O	588	591	see	see	VB	B-VP
O	592	597	below	below	IN	B-PP
O	597	598	)	)	)	O
O	599	602	and	and	CC	O
O	603	604	X	X	NN	B-NP
O	604	605	-	-	HYPH	I-NP
O	605	614	tremeGENE	tremeGENE	NN	I-NP
O	615	627	transfection	transfection	NN	I-NP
O	628	635	reagent	reagent	NN	I-NP
O	635	636	,	,	,	O
O	637	639	we	we	PRP	B-NP
O	640	652	investigated	investigate	VBD	B-VP
O	653	656	the	the	DT	B-NP
O	657	663	effect	effect	NN	I-NP
O	664	666	of	of	IN	B-PP
O	667	674	varying	vary	VBG	B-VP
O	675	678	the	the	DT	B-NP
O	679	693	concentrations	concentration	NNS	I-NP
O	694	696	of	of	IN	B-PP
O	697	705	gelatine	gelatine	NN	B-NP
O	706	709	and	and	CC	I-NP
O	710	717	sucrose	sucrose	NN	I-NP
O	718	720	in	in	IN	B-PP
O	721	724	the	the	DT	B-NP
O	725	733	printing	printing	NN	I-NP
O	734	742	solution	solution	NN	I-NP
O	742	743	.	.	.	O

O	744	749	These	These	DT	B-NP
O	750	758	reagents	reagent	NNS	I-NP
O	759	763	have	have	VBP	B-VP
O	764	768	been	be	VBN	I-VP
O	769	777	reported	report	VBN	I-VP
O	778	780	to	to	TO	I-VP
O	781	790	influence	influence	VB	I-VP
O	791	795	both	both	CC	O
O	796	799	the	the	DT	B-NP
O	800	812	transfection	transfection	NN	I-NP
O	813	823	efficiency	efficiency	NN	I-NP
O	824	827	and	and	CC	O
O	828	832	spot	spot	NN	B-NP
O	833	842	integrity	integrity	NN	I-NP
O	843	844	(	(	(	O
O	844	845	6	6	CD	B-NP
O	845	846	,	,	,	I-NP
O	846	848	27	27	CD	I-NP
O	848	849	)	)	)	O
O	849	850	.	.	.	O

O	851	858	Sucrose	Sucrose	NN	B-NP
O	859	862	was	be	VBD	B-VP
O	863	871	observed	observe	VBN	I-VP
O	872	874	to	to	TO	I-VP
O	875	877	be	be	VB	I-VP
O	878	890	specifically	specifically	RB	B-ADJP
O	891	901	beneficial	beneficial	JJ	I-ADJP
O	902	905	for	for	IN	B-PP
O	906	915	obtaining	obtain	VBG	B-VP
O	916	920	high	high	JJ	B-NP
O	921	933	transfection	transfection	NN	I-NP
O	934	944	efficiency	efficiency	NN	I-NP
O	945	949	when	when	WRB	B-ADVP
O	950	957	storing	store	VBG	B-VP
O	958	961	the	the	DT	B-NP
O	962	968	arrays	array	NNS	I-NP
O	969	972	for	for	IN	B-PP
O	973	980	several	several	JJ	B-NP
O	981	986	weeks	week	NNS	I-NP
O	987	993	before	before	IN	B-PP
O	994	997	use	use	NN	B-NP
O	998	999	(	(	(	O
O	999	1003	data	datum	NNS	B-NP
O	1004	1007	not	not	RB	B-VP
O	1008	1013	shown	show	VBN	I-VP
O	1013	1014	)	)	)	O
O	1014	1015	.	.	.	O

O	1016	1022	Figure	Figure	NN	B-NP
O	1023	1025	1A	1A	NN	I-NP
O	1026	1029	and	and	CC	I-NP
O	1030	1031	B	B	NN	I-NP
O	1032	1036	show	show	VBP	B-VP
O	1037	1051	representative	representative	JJ	B-NP
O	1052	1058	images	image	NNS	I-NP
O	1059	1061	of	of	IN	B-PP
O	1062	1065	the	the	DT	B-NP
O	1066	1074	observed	observe	VBN	I-NP
O	1075	1082	effects	effect	NNS	I-NP
O	1083	1085	of	of	IN	B-PP
O	1086	1093	varying	vary	VBG	B-VP
O	1094	1097	the	the	DT	B-NP
O	1098	1112	concentrations	concentration	NNS	I-NP
O	1113	1115	of	of	IN	B-PP
O	1116	1124	gelatine	gelatine	NN	B-NP
O	1125	1128	and	and	CC	I-NP
O	1129	1136	sucrose	sucrose	NN	I-NP
O	1136	1137	.	.	.	O

O	1138	1140	We	We	PRP	B-NP
O	1141	1149	observed	observe	VBD	B-VP
O	1150	1154	that	that	IN	B-SBAR
O	1155	1158	the	the	DT	B-NP
O	1159	1171	transfection	transfection	NN	I-NP
O	1172	1182	efficiency	efficiency	NN	I-NP
O	1183	1192	increased	increase	VBD	B-VP
O	1193	1197	with	with	IN	B-PP
O	1198	1208	increasing	increase	VBG	B-NP
O	1209	1217	gelatine	gelatine	NN	I-NP
O	1218	1231	concentration	concentration	NN	I-NP
O	1232	1233	(	(	(	O
O	1233	1239	tested	test	VBN	B-VP
O	1240	1242	in	in	IN	B-PP
O	1243	1246	the	the	DT	B-NP
O	1247	1252	range	range	NN	I-NP
O	1253	1254	0	0	CD	I-NP
O	1254	1255	.	.	.	I-NP
O	1255	1257	01	01	CD	I-NP
O	1257	1258	-	-	:	O
O	1258	1259	0	0	CD	B-NP
O	1259	1260	.	.	.	I-NP
O	1260	1262	40	40	CD	I-NP
O	1262	1263	%	%	NN	I-NP
O	1263	1264	)	)	)	O
O	1264	1265	.	.	.	O

O	1266	1273	However	However	RB	B-ADVP
O	1273	1274	,	,	,	O
O	1275	1277	an	an	DT	B-NP
O	1278	1287	increased	increase	VBN	I-NP
O	1288	1299	disturbance	disturbance	NN	I-NP
O	1300	1302	of	of	IN	B-PP
O	1303	1306	the	the	DT	B-NP
O	1307	1314	spatial	spatial	JJ	I-NP
O	1315	1325	definition	definition	NN	I-NP
O	1326	1328	of	of	IN	B-PP
O	1329	1332	the	the	DT	B-NP
O	1333	1338	spots	spot	NNS	I-NP
O	1339	1342	was	be	VBD	B-VP
O	1343	1351	observed	observe	VBN	I-VP
O	1352	1356	with	with	IN	B-PP
O	1357	1367	increasing	increase	VBG	B-NP
O	1368	1382	concentrations	concentration	NNS	I-NP
O	1383	1385	of	of	IN	B-PP
O	1386	1394	gelatine	gelatine	NN	B-NP
O	1395	1397	or	or	CC	I-NP
O	1398	1405	sucrose	sucrose	NN	I-NP
O	1406	1407	(	(	(	O
O	1407	1413	tested	test	VBN	B-VP
O	1414	1416	in	in	IN	B-PP
O	1417	1420	the	the	DT	B-NP
O	1421	1426	range	range	NN	I-NP
O	1427	1428	0	0	CD	I-NP
O	1428	1429	-	-	HYPH	I-NP
O	1429	1432	100	100	CD	I-NP
O	1433	1435	mM	mM	NN	I-NP
O	1435	1436	)	)	)	O
O	1436	1437	.	.	.	O

O	1438	1439	A	A	DT	B-NP
O	1440	1448	combined	combined	JJ	I-NP
O	1449	1455	effect	effect	NN	I-NP
O	1456	1458	of	of	IN	B-PP
O	1459	1462	the	the	DT	B-NP
O	1463	1477	concentrations	concentration	NNS	I-NP
O	1478	1480	of	of	IN	B-PP
O	1481	1489	gelatine	gelatine	NN	B-NP
O	1490	1493	and	and	CC	I-NP
O	1494	1501	sucrose	sucrose	NN	I-NP
O	1502	1505	was	be	VBD	B-VP
O	1506	1510	also	also	RB	I-VP
O	1511	1519	observed	observe	VBN	I-VP
O	1519	1520	,	,	,	O
O	1521	1523	as	as	IN	B-SBAR
O	1524	1527	low	low	JJ	B-NP
O	1528	1542	concentrations	concentration	NNS	I-NP
O	1543	1545	of	of	IN	B-PP
O	1546	1554	gelatine	gelatine	NN	B-NP
O	1555	1562	allowed	allow	VBD	B-VP
O	1563	1565	us	us	PRP	B-NP
O	1566	1568	to	to	TO	B-VP
O	1569	1572	use	use	VB	I-VP
O	1573	1579	higher	high	JJR	B-NP
O	1580	1594	concentrations	concentration	NNS	I-NP
O	1595	1597	of	of	IN	B-PP
O	1598	1605	sucrose	sucrose	NN	B-NP
O	1606	1610	than	than	IN	B-PP
O	1611	1615	with	with	IN	B-PP
O	1616	1622	higher	high	JJR	B-NP
O	1623	1637	concentrations	concentration	NNS	I-NP
O	1638	1640	of	of	IN	B-PP
O	1641	1649	gelatine	gelatine	NN	B-NP
O	1650	1656	before	before	IN	B-PP
B-Cell	1657	1662	cells	cell	NNS	B-NP
O	1663	1669	spread	spread	VBN	B-VP
O	1670	1677	outside	outside	IN	B-PP
O	1678	1681	the	the	DT	B-NP
O	1682	1687	spots	spot	NNS	I-NP
O	1687	1688	.	.	.	O

O	1689	1694	Based	Base	VBN	B-PP
O	1695	1697	on	on	IN	B-PP
O	1698	1705	several	several	JJ	B-NP
O	1706	1716	optimizing	optimize	VBG	I-NP
O	1717	1728	experiments	experiment	NNS	I-NP
O	1728	1729	,	,	,	O
O	1730	1732	we	we	PRP	B-NP
O	1733	1738	found	find	VBD	B-VP
O	1739	1743	that	that	IN	B-SBAR
O	1744	1745	3	3	CD	B-NP
O	1746	1752	microl	microl	NN	I-NP
O	1753	1754	X	X	NN	I-NP
O	1754	1755	-	-	HYPH	B-NP
O	1755	1764	tremeGENE	tremeGENE	NN	I-NP
O	1765	1773	solution	solution	NN	I-NP
O	1774	1777	per	per	IN	B-PP
O	1778	1787	microgram	microgram	NN	B-NP
O	1788	1795	nucleic	nucleic	JJ	B-NP
O	1796	1800	acid	acid	NN	I-NP
O	1800	1801	,	,	,	O
O	1802	1804	25	25	CD	B-NP
O	1805	1807	mM	mM	NN	I-NP
O	1808	1815	sucrose	sucrose	NN	I-NP
O	1816	1819	and	and	CC	O
O	1820	1821	0	0	CD	B-NP
O	1821	1822	.	.	.	O
O	1822	1823	1	1	CD	B-NP
O	1823	1824	%	%	NN	I-NP
O	1825	1833	gelatine	gelatine	NN	I-NP
O	1834	1836	in	in	IN	B-PP
O	1837	1840	the	the	DT	B-NP
O	1841	1846	final	final	JJ	I-NP
O	1847	1855	printing	printing	NN	I-NP
O	1856	1864	solution	solution	NN	I-NP
O	1865	1877	reproducibly	reproducibly	RB	B-ADVP
O	1878	1882	gave	give	VBD	B-VP
O	1883	1890	spatial	spatial	JJ	B-NP
O	1891	1901	restricted	restricted	JJ	I-NP
O	1902	1914	transfection	transfection	NN	I-NP
O	1915	1919	with	with	IN	B-PP
O	1920	1924	high	high	JJ	B-NP
O	1925	1937	transfection	transfection	NN	I-NP
O	1938	1948	efficiency	efficiency	NN	I-NP
O	1949	1957	printing	print	VBG	B-VP
O	1958	1961	the	the	DT	B-NP
O	1962	1968	arrays	array	NNS	I-NP
O	1969	1973	with	with	IN	B-PP
O	1974	1978	both	both	CC	O
O	1979	1980	a	a	DT	B-NP
O	1981	1988	pipette	pipette	NN	I-NP
O	1989	1992	tip	tip	NN	I-NP
O	1993	1996	and	and	CC	O
O	1997	1998	a	a	DT	B-NP
B-Organism_subdivision	1999	2003	hand	hand	NN	I-NP
O	2003	2004	-	-	HYPH	O
O	2004	2008	held	hold	VBN	B-NP
O	2009	2016	arrayer	arrayer	NN	I-NP
O	2017	2018	(	(	(	O
O	2018	2021	see	see	VB	B-VP
O	2022	2027	below	below	IN	B-PP
O	2027	2028	)	)	)	O
O	2028	2029	.	.	.	O

O	2031	2037	Figure	Figure	NN	B-NP
O	2038	2039	1	1	CD	I-NP
O	2039	2040	.	.	.	O

O	2041	2048	Effects	Effect	NNS	B-NP
O	2049	2051	of	of	IN	B-PP
O	2052	2059	sucrose	sucrose	NN	B-NP
O	2060	2063	and	and	CC	I-NP
O	2064	2072	gelatine	gelatine	NN	I-NP
O	2073	2087	concentrations	concentration	NNS	I-NP
O	2088	2090	on	on	IN	B-PP
O	2091	2095	spot	spot	NN	B-NP
O	2096	2105	integrity	integrity	NN	I-NP
O	2106	2109	and	and	CC	O
O	2110	2122	transfection	transfection	NN	B-NP
O	2123	2133	efficiency	efficiency	NN	I-NP
O	2133	2134	.	.	.	O

O	2135	2136	(	(	(	O
O	2136	2137	A	A	DT	O
O	2137	2138	)	)	)	O
O	2139	2144	Array	Array	NN	B-NP
O	2145	2152	printed	print	VBN	B-VP
O	2153	2157	with	with	IN	B-PP
O	2158	2164	pDsRed	pDsRe	VBN	B-VP
O	2165	2166	(	(	(	O
O	2166	2168	50	50	CD	B-NP
O	2169	2171	ng	ng	NN	I-NP
O	2171	2172	/	/	SYM	B-NP
O	2172	2178	microl	microl	NN	I-NP
O	2178	2179	)	)	)	O
O	2180	2182	in	in	IN	B-PP
O	2183	2184	a	a	DT	B-NP
O	2185	2193	printing	printing	NN	I-NP
O	2194	2202	solution	solution	NN	I-NP
O	2203	2207	with	with	IN	B-PP
O	2208	2217	different	different	JJ	B-NP
O	2218	2226	gelatine	gelatine	NN	I-NP
O	2227	2230	and	and	CC	I-NP
O	2231	2238	sucrose	sucrose	NN	I-NP
O	2239	2253	concentrations	concentration	NNS	I-NP
O	2253	2254	.	.	.	O

O	2255	2263	Scanning	Scanning	NN	B-NP
O	2264	2269	image	image	NN	I-NP
O	2270	2272	of	of	IN	B-PP
O	2273	2276	the	the	DT	B-NP
O	2277	2282	whole	whole	JJ	I-NP
O	2283	2288	array	array	NN	I-NP
O	2289	2292	and	and	CC	I-NP
O	2293	2307	magnifications	magnification	NNS	I-NP
O	2308	2310	of	of	IN	B-PP
O	2311	2319	specific	specific	JJ	B-NP
O	2320	2325	spots	spot	NNS	I-NP
O	2325	2326	.	.	.	O

O	2327	2328	(	(	(	O
O	2328	2329	B	B	NN	B-NP
O	2329	2330	)	)	)	O
O	2331	2336	Array	Array	NN	B-NP
O	2337	2344	printed	print	VBN	B-VP
O	2345	2349	with	with	IN	B-PP
O	2350	2355	pEGFP	pEGFP	NN	B-NP
O	2356	2357	(	(	(	O
O	2357	2359	50	50	CD	B-NP
O	2360	2362	ng	ng	NN	I-NP
O	2362	2363	/	/	SYM	B-NP
O	2363	2369	microl	microl	NN	I-NP
O	2369	2370	)	)	)	O
O	2371	2373	in	in	IN	B-PP
O	2374	2375	a	a	DT	B-NP
O	2376	2384	printing	printing	NN	I-NP
O	2385	2393	solution	solution	NN	I-NP
O	2394	2398	with	with	IN	B-PP
O	2399	2401	25	25	CD	B-NP
O	2402	2404	mM	mM	NN	I-NP
O	2405	2412	sucrose	sucrose	NN	I-NP
O	2413	2416	and	and	CC	O
O	2417	2421	four	four	CD	B-NP
O	2422	2431	different	different	JJ	I-NP
O	2432	2446	concentrations	concentration	NNS	I-NP
O	2447	2449	of	of	IN	B-PP
O	2450	2458	gelatine	gelatine	NN	B-NP
O	2458	2459	.	.	.	O

O	2460	2463	Top	Top	NNP	B-NP
O	2463	2464	:	:	:	O
O	2465	2468	Box	Box	NNP	B-NP
O	2469	2473	plot	plot	NN	I-NP
O	2474	2476	of	of	IN	B-PP
O	2477	2480	the	the	DT	B-NP
O	2481	2493	fluorescence	fluorescence	NN	I-NP
O	2494	2505	intensities	intensity	NNS	I-NP
O	2506	2508	in	in	IN	B-PP
O	2509	2513	each	each	DT	B-NP
O	2514	2518	spot	spot	NN	I-NP
O	2519	2520	(	(	(	O
O	2520	2521	n	n	NN	B-NP
O	2522	2523	=	=	SYM	B-VP
O	2524	2526	32	32	CD	B-NP
O	2526	2527	-	-	HYPH	I-NP
O	2527	2529	34	34	CD	I-NP
O	2529	2530	)	)	)	O
O	2530	2531	.	.	.	O

O	2532	2538	Bottom	Bottom	NN	B-NP
O	2538	2539	:	:	:	O
O	2540	2548	Scanning	Scanning	NN	B-NP
O	2549	2554	image	image	NN	I-NP
O	2555	2562	showing	show	VBG	B-VP
O	2563	2570	squares	square	NNS	B-NP
O	2571	2573	of	of	IN	B-PP
O	2574	2579	seven	seven	CD	B-NP
O	2580	2585	times	time	NNS	I-NP
O	2586	2590	five	five	CD	I-NP
O	2591	2596	spots	spot	NNS	I-NP
O	2597	2600	for	for	IN	B-PP
O	2601	2604	the	the	DT	B-NP
O	2605	2609	four	four	CD	I-NP
O	2610	2618	gelatine	gelatine	NN	I-NP
O	2619	2633	concentrations	concentration	NNS	I-NP
O	2633	2634	.	.	.	O

O	2635	2639	From	From	IN	B-PP
O	2640	2644	left	leave	VBN	B-VP
O	2645	2647	to	to	TO	B-PP
O	2648	2653	right	right	JJ	B-NP
O	2653	2654	:	:	:	O
O	2655	2656	0	0	CD	B-NP
O	2656	2657	.	.	.	O
O	2657	2659	01	01	CD	B-NP
O	2659	2660	,	,	,	I-NP
O	2661	2662	0	0	CD	I-NP
O	2662	2663	.	.	.	I-NP
O	2663	2665	05	05	CD	I-NP
O	2665	2666	,	,	,	I-NP
O	2667	2668	0	0	CD	I-NP
O	2668	2669	.	.	.	I-NP
O	2669	2670	1	1	CD	I-NP
O	2671	2674	and	and	CC	I-NP
O	2675	2676	0	0	CD	I-NP
O	2676	2677	.	.	.	O
O	2677	2678	2	2	CD	B-NP
O	2678	2679	%	%	NN	I-NP
O	2680	2688	gelatine	gelatine	NN	I-NP
O	2688	2689	.	.	.	O

O	2690	2693	The	The	DT	B-NP
O	2694	2697	DNA	DNA	NN	I-NP
O	2697	2698	-	-	HYPH	B-NP
O	2698	2703	lipid	lipid	NN	I-NP
O	2703	2704	-	-	HYPH	B-NP
O	2704	2712	gelatine	gelatine	NN	I-NP
O	2712	2713	-	-	HYPH	I-NP
O	2713	2720	sucrose	sucrose	NN	I-NP
O	2721	2730	solutions	solution	NNS	I-NP
O	2731	2735	were	be	VBD	B-VP
O	2736	2743	printed	print	VBN	I-VP
O	2744	2752	manually	manually	RB	B-ADVP
O	2753	2757	with	with	IN	B-PP
O	2758	2759	a	a	DT	B-NP
O	2760	2762	10	10	CD	I-NP
O	2763	2769	microl	microl	NN	I-NP
O	2770	2777	pipette	pipette	NN	I-NP
O	2778	2781	tip	tip	NN	I-NP
O	2782	2783	(	(	(	O
O	2783	2784	A	A	NN	B-NP
O	2784	2785	)	)	)	O
O	2786	2788	or	or	CC	O
O	2789	2791	by	by	IN	B-PP
O	2792	2805	MicroCasterTM	MicroCasterTM	NNP	B-NP
O	2806	2812	manual	manual	JJ	I-NP
O	2813	2820	arrayer	arrayer	NN	I-NP
O	2821	2827	system	system	NN	I-NP
O	2828	2829	(	(	(	O
O	2829	2830	B	B	NN	B-NP
O	2830	2831	)	)	)	O
O	2831	2832	.	.	.	O

O	2833	2835	In	In	IN	B-PP
O	2836	2837	a	a	DT	B-NP
O	2838	2839	1	1	CD	I-NP
O	2839	2840	.	.	.	I-NP
O	2840	2841	5	5	CD	I-NP
O	2842	2844	ml	ml	NN	I-NP
O	2845	2860	microcentrifuge	microcentrifuge	NN	I-NP
O	2861	2865	tube	tube	NN	I-NP
O	2865	2866	,	,	,	O
B-Cellular_component	2867	2874	plasmid	plasmid	NN	B-NP
O	2875	2876	(	(	(	O
O	2876	2877	1	1	CD	B-NP
O	2878	2884	microg	microg	NN	I-NP
O	2884	2885	/	/	SYM	B-NP
O	2885	2891	microl	microl	NN	I-NP
O	2891	2892	)	)	)	O
O	2893	2896	and	and	CC	O
O	2897	2902	siRNA	siRNA	NN	B-NP
O	2903	2907	were	be	VBD	B-VP
O	2908	2913	mixed	mix	VBN	B-ADJP
O	2914	2918	with	with	IN	B-PP
O	2919	2925	growth	growth	NN	B-NP
O	2926	2932	medium	medium	NN	I-NP
O	2933	2940	without	without	IN	B-PP
B-Organism_substance	2941	2946	fetal	fetal	JJ	B-NP
I-Organism_substance	2947	2951	calf	calf	NN	I-NP
I-Organism_substance	2952	2957	serum	serum	NN	I-NP
O	2958	2959	(	(	(	O
B-Organism_substance	2959	2962	FCS	FCS	NN	B-NP
O	2962	2963	)	)	)	O
O	2963	2964	,	,	,	O
O	2965	2966	0	0	CD	B-NP
O	2966	2967	.	.	.	O
O	2967	2968	5	5	CD	B-NP
O	2969	2975	microl	microl	NN	I-NP
O	2976	2977	1	1	CD	I-NP
O	2977	2978	.	.	.	O
O	2978	2979	5	5	CD	B-NP
O	2980	2981	M	M	NN	I-NP
O	2982	2989	sucrose	sucrose	NN	I-NP
O	2990	2993	and	and	CC	O
O	2994	2995	3	3	CD	B-NP
O	2996	3002	microl	microl	NN	I-NP
O	3003	3004	X	X	SYM	O
O	3004	3005	-	-	HYPH	O
O	3005	3014	tremeGENE	tremeGENE	NN	B-NP
O	3015	3018	per	per	IN	B-PP
O	3019	3028	microgram	microgram	NN	B-NP
O	3029	3036	nucleic	nucleic	JJ	B-NP
O	3037	3041	acid	acid	NN	I-NP
O	3042	3044	to	to	TO	B-PP
O	3045	3046	a	a	DT	B-NP
O	3047	3052	final	final	JJ	I-NP
O	3053	3059	volume	volume	NN	I-NP
O	3060	3062	of	of	IN	B-PP
O	3063	3065	22	22	CD	B-NP
O	3065	3066	.	.	.	O
O	3066	3067	5	5	CD	B-NP
O	3068	3074	microl	microl	NN	I-NP
O	3074	3075	.	.	.	O

O	3076	3081	After	After	IN	B-PP
O	3082	3084	15	15	CD	B-NP
O	3084	3085	-	-	HYPH	I-NP
O	3085	3087	20	20	CD	I-NP
O	3088	3091	min	min	NN	I-NP
O	3092	3094	of	of	IN	B-PP
O	3095	3105	incubation	incubation	NN	B-NP
O	3105	3106	,	,	,	O
O	3107	3108	7	7	CD	B-NP
O	3108	3109	.	.	.	O
O	3109	3110	5	5	CD	B-NP
O	3111	3117	microl	microl	NN	I-NP
O	3118	3119	0	0	CD	I-NP
O	3119	3120	.	.	.	O
O	3120	3121	4	4	CD	B-NP
O	3121	3122	%	%	NN	I-NP
O	3123	3131	gelatine	gelatine	NN	I-NP
O	3132	3133	(	(	(	O
O	3133	3137	Type	Type	NN	B-NP
O	3138	3139	B	B	NN	I-NP
O	3139	3140	,	,	,	O
O	3141	3146	G9391	G9391	NN	B-NP
O	3146	3147	,	,	,	O
O	3148	3153	Sigma	Sigma	NNP	B-NP
O	3153	3154	)	)	)	O
O	3155	3158	was	be	VBD	B-VP
O	3159	3164	added	add	VBN	I-VP
O	3165	3167	to	to	TO	I-VP
O	3168	3172	give	give	VB	I-VP
O	3173	3175	30	30	CD	B-NP
O	3176	3182	microl	microl	NN	I-NP
O	3183	3191	printing	printing	NN	I-NP
O	3192	3200	solution	solution	NN	I-NP
O	3200	3201	.	.	.	O

O	3202	3205	The	The	DT	B-NP
O	3206	3214	gelatine	gelatine	NN	I-NP
O	3215	3223	solution	solution	NN	I-NP
O	3224	3227	was	be	VBD	B-VP
O	3228	3236	prepared	prepare	VBN	I-VP
O	3237	3239	as	as	IN	B-SBAR
O	3240	3249	described	describe	VBN	B-VP
O	3250	3252	by	by	IN	B-PP
O	3253	3261	Ziauddin	Ziauddin	NN	B-NP
O	3262	3265	and	and	CC	O
O	3266	3274	Sabatini	Sabatini	NNP	B-NP
O	3275	3276	(	(	(	O
O	3276	3277	1	1	CD	B-NP
O	3277	3278	)	)	)	O
O	3278	3279	.	.	.	O

O	3280	3282	To	To	TO	B-VP
O	3283	3290	achieve	achieve	VB	I-VP
O	3291	3301	sufficient	sufficient	JJ	B-NP
O	3302	3307	level	level	NN	I-NP
O	3308	3310	of	of	IN	B-PP
O	3311	3321	expression	expression	NN	B-NP
O	3322	3326	from	from	IN	B-PP
O	3327	3330	the	the	DT	B-NP
O	3331	3342	transfected	transfecte	VBN	I-NP
B-Cellular_component	3343	3351	plasmids	plasmid	NNS	I-NP
O	3351	3352	,	,	,	O
O	3353	3355	25	25	CD	B-NP
O	3355	3356	-	-	HYPH	I-NP
O	3356	3358	50	50	CD	I-NP
O	3359	3361	ng	ng	NN	I-NP
O	3361	3362	/	/	SYM	B-NP
O	3362	3368	microl	microl	NN	B-NP
O	3369	3374	pEGFP	pEGFP	NN	I-NP
O	3374	3375	-	-	HYPH	B-NP
O	3375	3377	N1	N1	NN	I-NP
O	3378	3380	or	or	CC	O
O	3381	3387	pDsRed	pDsRed	JJ	B-NP
O	3387	3388	-	-	HYPH	I-NP
O	3388	3395	express	express	NN	I-NP
O	3395	3396	-	-	HYPH	I-NP
O	3396	3398	N1	N1	NN	I-NP
O	3399	3402	and	and	CC	I-NP
O	3403	3405	50	50	CD	I-NP
O	3405	3406	-	-	HYPH	I-NP
O	3406	3408	75	75	CD	I-NP
O	3409	3411	ng	ng	NN	I-NP
O	3411	3412	/	/	SYM	B-NP
O	3412	3418	microl	microl	NN	I-NP
O	3419	3421	of	of	IN	B-PP
O	3422	3425	CRE	CRE	NN	B-NP
O	3426	3428	or	or	CC	I-NP
O	3429	3437	NFkappaB	NFkappaB	NN	I-NP
O	3438	3446	reporter	reporter	NN	I-NP
B-Cellular_component	3447	3455	plasmids	plasmid	NNS	I-NP
O	3456	3459	was	be	VBD	B-VP
O	3460	3464	used	use	VBN	I-VP
O	3464	3465	.	.	.	O

O	3466	3469	For	For	IN	B-PP
O	3470	3475	siRNA	siRNA	NN	B-NP
O	3476	3483	studies	study	NNS	I-NP
O	3483	3484	,	,	,	O
O	3485	3486	2	2	CD	B-NP
O	3486	3487	-	-	HYPH	I-NP
O	3487	3489	30	30	CD	I-NP
O	3490	3492	ng	ng	NN	I-NP
O	3492	3493	/	/	SYM	B-NP
O	3493	3499	microl	microl	NN	I-NP
O	3500	3505	siRNA	siRNA	NN	I-NP
O	3506	3508	in	in	IN	B-PP
O	3509	3512	the	the	DT	B-NP
O	3513	3518	final	final	JJ	I-NP
O	3519	3527	printing	printing	NN	I-NP
O	3528	3536	solution	solution	NN	I-NP
O	3537	3540	was	be	VBD	B-VP
O	3541	3545	used	use	VBN	I-VP
O	3545	3546	.	.	.	O

